Document Detail


Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.
MedLine Citation:
PMID:  23539465     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
This systematic review examines treatment guidelines, efficacy/effectiveness, and tolerability regarding the use of antipsychotics concurrently with psychostimulants in treating aggression and hyperactivity in children and adolescents. Articles examining the concurrent use of antipsychotics and psychostimulants to treat comorbid attention deficit/hyperactivity disorder (ADHD) and disruptive behavior disorders (DBDs) were identified and their results were summarized and critically analyzed. Antipsychotic and stimulant combination therapy is recommended by some guidelines, but only as a third-line treatment following stimulant monotherapy and stimulants combined with behavioral interventions to treat aggression in patients with ADHD. Some studies suggest efficacy/effectiveness for an antipsychotic and stimulant combination in the treatment of aggression and hyperactivity in children and adolescents. However, the data do not clearly demonstrate superiority compared to antipsychotic or psychostimulant monotherapy. Most studies were performed over short time periods, several lacked blinding, few studies used any placebo control, and no comparisons were made with behavioral interventions. There are concerns about the tolerability of combination therapy, but data do not suggest significantly worse adverse effects for combination compared to either antipsychotic or stimulant monotherapy. Conversely, and contrary to speculation, use of a stimulant does not significantly reduce metabolic effects of antipsychotics. Combination treatment with antipsychotics and psychostimulants is used frequently, and increasingly more often. Few studies have directly examined this combination for the treatment of ADHD and DBDs. Further studies are necessary to confirm the efficacy and tolerability of the concurrent use of antipsychotics and psychostimulants in children and adolescents.
Authors:
David Linton; Alasdair M Barr; William G Honer; Ric M Procyshyn
Related Documents :
23093475 - Comparing augmentation with non-antidepressants over sticking to antidepressants after ...
23200525 - Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a...
10364995 - Placebo-controlled study of inhaled nitric oxide to treat hypoxaemia during one-lung ve...
20069855 - Applying imidacloprid via a precision banding system to control striped cucumber beetle...
8748385 - Cognitive-behavior therapy for generalized anxiety disorder.
11190005 - Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis c.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current psychiatry reports     Volume:  15     ISSN:  1535-1645     ISO Abbreviation:  Curr Psychiatry Rep     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-03-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888960     Medline TA:  Curr Psychiatry Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  355     Citation Subset:  IM    
Affiliation:
British Columbia Mental Health and Addictions Research Institute, A3-938 W 28th Avenue, Vancouver, B.C., V5Z 4H4, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Outcomes of conjunctival compression sutures for hypotony after glaucoma filtering surgery.
Next Document:  Self-rated health and life satisfaction among Canadian adults: associations of perceived weight stat...